Berenberg lowered the firm’s price target on Sanofi (SNY) to EUR 118 from EUR 120 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- Oppenheimer bullish on Nurix as Sanofi opt-in, competitor data derisk STAT6
- Sanofi price target lowered to EUR 108 from EUR 121 at Guggenheim
- Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
- Sanofi acquisition of Blueprint Medicines ‘sensible,’ says BofA
- Sanofi exercises license extension option to Nurix’s STAT6 program